UBS Group’s Arrowhead Research ARWR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $83.8M | Buy |
1,336,271
+348,984
| +35% | +$22.1M | 0.01% | 1192 |
|
|
2025
Q4 | $65.5M | Buy |
987,287
+69,104
| +8% | +$3.39M | 0.01% | 1362 |
|
|
2025
Q3 | $31.7M | Sell |
918,183
-682,413
| -43% | -$15M | 0.01% | 2073 |
|
|
2025
Q2 | $25.3M | Sell |
1,600,596
-25,967
| -2% | -$373K | ﹤0.01% | 2132 |
|
|
2025
Q1 | $20.7M | Buy |
1,626,563
+321,234
| +25% | +$5.84M | ﹤0.01% | 2285 |
|
|
2024
Q4 | $24.5M | Buy |
1,305,329
+863,818
| +196% | +$17.8M | ﹤0.01% | 2120 |
|
|
2024
Q3 | $8.55M | Buy |
441,511
+93,207
| +27% | +$2.27M | ﹤0.01% | 2518 |
|
|
2024
Q2 | $9.05M | Sell |
348,304
-102,617
| -23% | -$2.52M | ﹤0.01% | 2293 |
|
|
2024
Q1 | $12.9M | Sell |
450,921
-57,665
| -11% | -$1.84M | ﹤0.01% | 2054 |
|
|
2023
Q4 | $15.6M | Buy |
508,586
+138,984
| +38% | +$3.69M | ﹤0.01% | 1763 |
|
|
2023
Q3 | $9.93M | Buy |
369,602
+38,632
| +12% | +$1.18M | ﹤0.01% | 1987 |
|
|
2023
Q2 | $11.8M | Buy |
330,970
+31,628
| +11% | +$1.09M | ﹤0.01% | 1846 |
|
|
2023
Q1 | $7.6M | Sell |
299,342
-8,368
| -3% | -$263K | ﹤0.01% | 2125 |
|
|
2022
Q4 | $12.5M | Buy |
307,710
+204,164
| +197% | +$6.76M | ﹤0.01% | 1752 |
|
|
2022
Q3 | $3.42M | Buy |
103,546
+12,329
| +14% | +$498K | ﹤0.01% | 2685 |
|
|
2022
Q2 | $3.21M | Sell |
91,217
-68,109
| -43% | -$2.56M | ﹤0.01% | 2738 |
|
|
2022
Q1 | $7.33M | Buy |
159,326
+4,310
| +3% | +$213K | ﹤0.01% | 2195 |
|
|
2021
Q4 | $10.3M | Buy |
155,016
+25,016
| +19% | +$1.72M | ﹤0.01% | 2118 |
|
|
2021
Q3 | $8.12M | Buy |
130,000
+57,787
| +80% | +$3.74M | ﹤0.01% | 2212 |
|
|
2021
Q2 | $5.98M | Buy |
72,213
+272
| +0.4% | +$20.3K | ﹤0.01% | 2500 |
|
|
2021
Q1 | $4.77M | Buy |
71,941
+60,386
| +523% | +$4.69M | ﹤0.01% | 2645 |
|
|
2020
Q4 | $887K | Sell |
11,555
-21,583
| -65% | -$1.38M | ﹤0.01% | 4111 |
|
|
2020
Q3 | $1.43M | Buy |
33,138
+25,334
| +325% | +$1.09M | ﹤0.01% | 3374 |
|
|
2020
Q2 | $337K | Sell |
7,804
-4,249
| -35% | -$150K | ﹤0.01% | 4430 |
|
|
2020
Q1 | $347K | Sell |
12,053
-196,122
| -94% | -$7.91M | ﹤0.01% | 4290 |
|
|
2019
Q4 | $13.2M | Sell |
208,175
-3,236
| -2% | -$161K | ﹤0.01% | 1700 |
|
|
2019
Q3 | $5.96M | Buy |
211,411
+96,985
| +85% | +$2.87M | ﹤0.01% | 2214 |
|
|
2019
Q2 | $3.03M | Buy |
114,426
+59,812
| +110% | +$1.31M | ﹤0.01% | 2774 |
|
|
2019
Q1 | $1M | Sell |
54,614
-224,405
| -80% | -$3.7M | ﹤0.01% | 3589 |
|
|
2018
Q4 | $3.46M | Buy |
279,019
+195,436
| +234% | +$2.67M | ﹤0.01% | 2511 |
|
|
2018
Q3 | $1.6M | Buy |
83,583
+50,443
| +152% | +$828K | ﹤0.01% | 3412 |
|
|
2018
Q2 | $451K | Sell |
33,140
-169,625
| -84% | -$1.59M | ﹤0.01% | 4391 |
|
|
2018
Q1 | $1.46M | Buy |
202,765
+180,186
| +798% | +$1.11M | ﹤0.01% | 3385 |
|
|
2017
Q4 | $83K | Buy |
22,579
+10,681
| +90% | +$39.7K | ﹤0.01% | 5483 |
|
|
2017
Q3 | $51K | Buy |
11,898
+6,241
| +110% | +$14.9K | ﹤0.01% | 5774 |
|
|
2017
Q2 | $10K | Buy |
5,657
+357
| +7% | +$578 | ﹤0.01% | 6764 |
|
|
2017
Q1 | $10K | Sell |
5,300
-9,380
| -64% | -$18.6K | ﹤0.01% | 6596 |
|
|
2016
Q4 | $23K | Sell |
14,680
-6,280
| -30% | -$26.8K | ﹤0.01% | 6420 |
|
|
2016
Q3 | $154K | Buy |
20,960
+12,410
| +145% | +$80.4K | ﹤0.01% | 4722 |
|
|
2016
Q2 | $45K | Sell |
8,550
-264
| -3% | -$1.51K | ﹤0.01% | 5597 |
|
|
2016
Q1 | $43K | Buy |
8,814
+2,016
| +30% | +$8.5K | ﹤0.01% | 5606 |
|
|
2015
Q4 | $43K | Buy |
6,798
+3,398
| +100% | +$19.3K | ﹤0.01% | 5944 |
|
|
2015
Q3 | $20K | Sell |
3,400
-18,209
| -84% | -$115K | ﹤0.01% | 6682 |
|
|
2015
Q2 | $154K | Sell |
21,609
-98,114
| -82% | -$674K | ﹤0.01% | 5087 |
|
|
2015
Q1 | $810K | Buy |
119,723
+81,842
| +216% | +$581K | ﹤0.01% | 3752 |
|
|
2014
Q4 | $279K | Buy |
+37,881
| New | +$258K | ﹤0.01% | 4716 |
|
Other funds holding ARWR
ACA
VPM
VCM
FAM
VPC
UBS Group's ARWR Position: Q1 2026 in Review
UBS Group increased its Arrowhead Research (ARWR) stake by 35% in Q1 2026, buying an estimated $22.1M and bringing the position to 1,336,271 shares worth $83.8M. The position accounts for 0.01% of the portfolio, ranked #1192.
UBS Group first reported a position in ARWR in Q4 2014 and has held it in 46 quarters since. 436 funds tracked by Wall St. Rank hold ARWR as of Q1 2026.
- UBS Group held 1,336,271 shares of Arrowhead Research worth $83.8M as of Q1 2026.
- UBS Group bought 348,984 Arrowhead Research shares in Q1 2026, an estimated $22.1M.
- Arrowhead Research made up 0.01% of UBS Group's portfolio in Q1 2026, its #1192 holding.
- UBS Group first reported a position in Arrowhead Research in Q4 2014 and has held it in 46 quarters since.
- 436 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.